Miyuki Hohokabe

Title: The Innovative Contributions of Miyuki Hohokabe

Introduction

Miyuki Hohokabe is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of cocrystals and solid preparations. With a total of 2 patents, her work has the potential to impact the medical industry positively.

Latest Patents

Hohokabe's latest patents include a cocrystal production method and a medicament containing a cocrystal. The first patent provides a cocrystal of (S)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1H-1,2,4-triazol-5(4H)-one and an organic acid capable of forming a cocrystal with the compound. The second patent details a solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile, which serves as a pharmaceutically active ingredient.

Career Highlights

Miyuki Hohokabe is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. Her role involves research and development, focusing on innovative solutions for complex medical challenges. Hohokabe's expertise in cocrystal technology positions her as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout her career, Hohokabe has collaborated with notable colleagues, including Koya Kimoto and Mitsuo Yamamoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Miyuki Hohokabe's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts highlight her importance as an inventor. Her work continues to pave the way for advancements in medical treatments and drug formulations.